Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?

Detalles Bibliográficos
Autores principales: Choby, Jacob E, Ozturk, Tugba, Satola, Sarah W, Jacob, Jesse T, Weiss, David S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743357/
https://www.ncbi.nlm.nih.gov/pubmed/35544102
http://dx.doi.org/10.1016/S2666-5247(21)00271-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743357/
https://www.ncbi.nlm.nih.gov/pubmed/35544102
http://dx.doi.org/10.1016/S2666-5247(21)00271-8

Ejemplares similares